313 related articles for article (PubMed ID: 15023358)
1. Protein kinases as targets for anti-parasitic chemotherapy.
Doerig C
Biochim Biophys Acta; 2004 Mar; 1697(1-2):155-68. PubMed ID: 15023358
[TBL] [Abstract][Full Text] [Related]
2. Protein kinases as targets for antiparasitic chemotherapy drugs.
Canduri F; Perez PC; Caceres RA; de Azevedo WF
Curr Drug Targets; 2007 Mar; 8(3):389-98. PubMed ID: 17348832
[TBL] [Abstract][Full Text] [Related]
3. The cell cycle of parasitic protozoa: potential for chemotherapeutic exploitation.
Hammarton TC; Mottram JC; Doerig C
Prog Cell Cycle Res; 2003; 5():91-101. PubMed ID: 14593704
[TBL] [Abstract][Full Text] [Related]
4. Protein kinases as drug targets in parasitic protozoa.
Doerig C; Meijer L; Mottram JC
Trends Parasitol; 2002 Aug; 18(8):366-71. PubMed ID: 12377287
[TBL] [Abstract][Full Text] [Related]
5. Antiparasitic chemotherapy: tinkering with the purine salvage pathway.
Datta AK; Datta R; Sen B
Adv Exp Med Biol; 2008; 625():116-32. PubMed ID: 18365663
[TBL] [Abstract][Full Text] [Related]
6. Inhibitors of the Purine Salvage Pathway: A Valuable Approach for Antiprotozoal Chemotherapy?
Berg M; Van der Veken P; Goeminne A; Haemers A; Augustyns K
Curr Med Chem; 2010; 17(23):2456-81. PubMed ID: 20491648
[TBL] [Abstract][Full Text] [Related]
7. New mechanisms of drug resistance in parasitic protozoa.
Borst P; Ouellette M
Annu Rev Microbiol; 1995; 49():427-60. PubMed ID: 8561467
[TBL] [Abstract][Full Text] [Related]
8. Protein kinases as targets for antimalarial intervention: Kinomics, structure-based design, transmission-blockade, and targeting host cell enzymes.
Doerig C; Billker O; Pratt D; Endicott J
Biochim Biophys Acta; 2005 Dec; 1754(1-2):132-50. PubMed ID: 16271522
[TBL] [Abstract][Full Text] [Related]
9. Aspartic proteases of Plasmodium falciparum and other parasitic protozoa as drug targets.
Coombs GH; Goldberg DE; Klemba M; Berry C; Kay J; Mottram JC
Trends Parasitol; 2001 Nov; 17(11):532-7. PubMed ID: 11872398
[TBL] [Abstract][Full Text] [Related]
10. DNA topoisomerases as targets for antiprotozoal therapy.
Bakshi RP; Shapiro TA
Mini Rev Med Chem; 2003 Sep; 3(6):597-608. PubMed ID: 12871162
[TBL] [Abstract][Full Text] [Related]
11. Characterization of Plasmodium falciparum cGMP-dependent protein kinase (PfPKG): antiparasitic activity of a PKG inhibitor.
Diaz CA; Allocco J; Powles MA; Yeung L; Donald RG; Anderson JW; Liberator PA
Mol Biochem Parasitol; 2006 Mar; 146(1):78-88. PubMed ID: 16325279
[TBL] [Abstract][Full Text] [Related]
12. The effect of novel [3-fluoro-(2-phosphonoethoxy)propyl]purines on the inhibition of Plasmodium falciparum, Plasmodium vivax and human hypoxanthine-guanine-(xanthine) phosphoribosyltransferases.
Baszczyňski O; Hocková D; Janeba Z; Holý A; Jansa P; Dračínský M; Keough DT; Guddat LW
Eur J Med Chem; 2013 Sep; 67():81-9. PubMed ID: 23850568
[TBL] [Abstract][Full Text] [Related]
13. Targeting the cell cycle in the pursuit of novel chemotherapies against parasitic protozoa.
Grant KM
Curr Pharm Des; 2008; 14(9):917-24. PubMed ID: 18473840
[TBL] [Abstract][Full Text] [Related]
14. Malaria: targeting parasite and host cell kinomes.
Doerig C; Abdi A; Bland N; Eschenlauer S; Dorin-Semblat D; Fennell C; Halbert J; Holland Z; Nivez MP; Semblat JP; Sicard A; Reininger L
Biochim Biophys Acta; 2010 Mar; 1804(3):604-12. PubMed ID: 19840874
[TBL] [Abstract][Full Text] [Related]
15. Intracellular targets of cyclin-dependent kinase inhibitors: identification by affinity chromatography using immobilised inhibitors.
Knockaert M; Gray N; Damiens E; Chang YT; Grellier P; Grant K; Fergusson D; Mottram J; Soete M; Dubremetz JF; Le Roch K; Doerig C; Schultz P; Meijer L
Chem Biol; 2000 Jun; 7(6):411-22. PubMed ID: 10873834
[TBL] [Abstract][Full Text] [Related]
16. Targeting malaria with specific CDK inhibitors.
Geyer JA; Prigge ST; Waters NC
Biochim Biophys Acta; 2005 Dec; 1754(1-2):160-70. PubMed ID: 16185941
[TBL] [Abstract][Full Text] [Related]
17. Selection of targets for drug development against protozoan parasites.
de Azevedo WF; Soares MB
Curr Drug Targets; 2009 Mar; 10(3):193-201. PubMed ID: 19275556
[TBL] [Abstract][Full Text] [Related]
18. Bioinformatic analysis of glycogen synthase kinase 3: human versus parasite kinases.
Osolodkin DI; Zakharevich NV; Palyulin VA; Danilenko VN; Zefirov NS
Parasitology; 2011 May; 138(6):725-35. PubMed ID: 21349219
[TBL] [Abstract][Full Text] [Related]
19. ABC transporters and drug resistance in parasitic protozoa.
Klokouzas A; Shahi S; Hladky SB; Barrand MA; van Veen HW
Int J Antimicrob Agents; 2003 Sep; 22(3):301-17. PubMed ID: 13678838
[TBL] [Abstract][Full Text] [Related]
20. Transition state analogue inhibitors of protozoan nucleoside hydrolases.
Furneaux RH; Schramm VL; Tyler PC
Bioorg Med Chem; 1999 Nov; 7(11):2599-606. PubMed ID: 10632070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
